Home Saga Diagnostics

Saga Diagnostics

SAGA Diagnostics Raises 40 Million SEK (€3.7 Million)

Hadean Ventures, a Nordic focused European life science fund manager, leads the round, and is joined by a number of existing shareholders including Fårö Capital and the Gunnar Nilsson Cancer Foundation.